Hinge Health Inc.
HNGE Healthcare Health Information Services
Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024.
- Revenue
- +53.0%
- EPS
- +104.2%
- Free cash flow
- +441.1%
Quarter to June 2026, against a year earlier
Follow HNGE
Alert me
Hinge Health Inc. (HNGE) Net margin
Hinge Health Inc.'s net margin over the twelve months to 30 June 2026 was 14.9%, up 87.0 percentage points from fiscal 2025 (−72.1%). That is above the Health Information Services industry median of −16.1% and above the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | −72.1% | (69.08) |
| FY2024 | −3.06% | 33.88 |
| FY2023 | −36.9% | — |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Jun 2026 | 20.3% | 1.59 |
| Mar 2026 | 18.7% | (0.14) |
| Dec 2025 | 18.8% | 20.00 |
| Sep 2025 | −1.20% | 412.65 |
| 4 more quarters | Free account |
Net margin against peers
| Company | Net margin |
|---|---|
| DOCS Doximity, Inc. compare | 21.1% |
| HQY HealthEquity, Inc. compare | 17.4% |
| HNGE Hinge Health Inc. | 14.9% |
| WAY Waystar Holding Corp. compare | 10.7% |
| BTSG BrightSpring Health Services, Inc. compare | 2.69% |
| PRVA Privia Health Group, Inc. compare | 1.43% |
| TEM Tempus AI, Inc. compare | −12.5% |
| SDGR Schrodinger, Inc. compare | −22.0% |
| HTFL Heartflow, Inc. compare | −55.8% |
| Health Information Services industry median | −16.1% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on HNGE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement